Zyga Technology, a developer of minimally invasive surgical solutions, has enrolled first patient in its Glyder Facet Resurfacing System clinical study in Europe.

The multi-center, prospective study is designed to assess the safety and effectiveness of the Glyder device in patients with a history of facet pain.

BG-Clinic Bergmannstrost Department of Neurosurgery Chair and Center of Neurosciences director Hans Jorg Meisel professor said the first postoperative examinations showed a good result concerning the patients’ lumbar pain giving them the impression of a favorable outcome from the Glyder surgery.

"We look forward to continuing the study and reporting the final results," Meisel said.